Formation of ceramide-enriched domains in lipid particles enhances the binding of apolipoprotein E

FEBS Letters

Volumn 579, Issue 7, 2005, Pages 1759-1764

  Morita, Shin Ya ^a   Nakano, Minoru ^a   Sakurai, Atsushi ^a   Deharu, Yuko ^a   Vertut Doï, Aline ^a   Handa, Tetsurou ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E; Ceramide; Confocal fluorescence microscopy; Microdomain; Sphingomyelinase

Indexed keywords

APOLIPOPROTEIN E; CERAMIDE; LIPID; LIPID EMULSION; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ARTICLE; EMULSION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

EID: 14844318000     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.02.018     Document Type: Article

References (38)

1. X. Jiang, F. Paultre, T.A. Pearson, R.G. Reed, C.K. Francis, M. Lin, L. Berglund, and A.R. Tall Plasma sphingomyelin level as a risk factor for coronary artery disease Arterioscler. Thromb. Vasc. Biol. 20 2000 2614 2618
2. A.H. Merrill Jr, S. Lingrell, E. Wang, M. Nikolana-Karakashian, T.R. Valen, and D.E. Vance Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion J. Biol. Chem. 270 1995 13834 13841
3. S.L. Schissel, X. Jiang, J. Tweedie-Hardman, T. Jeong, E.H. Camejo, J. Najib, J.H. Rapp, K.J. Williams, and I. Tabas Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development J. Biol. Chem. 273 1998 2738 2746
4. S. Marathe, S.L. Schissel, M.J. Yellin, N. Beatini, R. Mintzer, K.J. Williams, and I. Tabas Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling J. Biol. Chem. 273 1998 4081 4088
5. S.L. Schissel, J. Tweedie-Hardman, J.H. Rapp, G. Graham, K.J. Williams, and I. Tabas Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins J. Clin. Invest. 98 1996 1455 1464
6. X.-X. Xu, and I. Tabas Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages J. Biol. Chem. 266 1991 24849 24858
7. K. Oörni, J.K. Hakala, A. Annila, M. Ala-Korpela, and P.T. Kovanen Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans J. Biol. Chem. 273 1998 29127 29134
8. J.M. Holopainen, O.P. Medina, A.J. Metso, and P.K.J. Kinnunen Sphingomyelinase activity associated with human plasma low density lipoprotein J. Biol. Chem. 275 2000 16484 16489
9. P.K.J. Kinnunen, and J.M. Holopainen Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis? Trends. Cardiovasc. Med. 12 2002 37 42
10. S. Marathe, Y. Choi, A.R. Leventhal, and I. Tabas Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation Arterioscler. Thromb. Vasc. Biol. 20 2000 2607 2613
11. S. Morita, K. Okuhira, N. Tsuchimoto, A. Vertut-Doï, H. Saito, M. Nakano, and T. Handa Effects of sphingomyelin on apolipoprotein E- and lipoprotein lipase-mediated cell uptake of lipid particles Biochim. Biophys. Acta 1631 2003 169 176
12. S. Morita, M. Kawabe, A. Sakurai, K. Okuhira, A. Vertut-Doï, M. Nakano, and T. Handa Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages J. Biol. Chem. 279 2004 24355 24361
13. S. Ylä-Herttuala, O. Jaakkola, C. Ehnholm, M.J. Tikkanen, T. Solakivi, T. Särkioja, and T. Nikkari Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima J. Lipid Res. 29 1988 563 572
14. V.I. Zannis, F.S. Cole, C.L. Jackson, D.M. Kurnit, and S.K. Karathanasis Distribution of apolipoprotein A-I C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages Biochemistry 24 1985 4450 4455
15. S. Fazio, V.R. Babaev, A.B. Murray, A.H. Hasty, K.J. Carter, L.A. Gleaves, J.B. Atkinson, and M.F. Linton Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages Proc. Natl. Acad. Sci. USA 94 1997 4647 4652
16. S. Yokoyama, Y. Kawai, S. Tajima, and A. Yamamoto Behavior of human apolipoprotein E in aqueous solutions and at interfaces J. Biol. Chem. 260 1985 16375 16382
17. J.M. Holopainen, H.L. Brockman, R.E. Brown, and P.K.J. Kinnunen Interfacial interactions of ceramide with dimyristoylphosphatidylcholine: impact of the N-acyl chain Biophys. J. 80 2001 765 775
18. J. Korlach, P. Schwille, W.W. Webb, and G.W. Feigenson Characterization of lipid bilayer phases by confocal microscopy and fluorescence correlation spectroscopy Proc. Natl. Acad. Sci. USA 96 1999 8461 8466
19. G.W. Feigenson, and J.T. Buboltz Ternary phase diagram of dipalmitoyl-PC/dilauroyl-PC/cholesterol: nanoscopic domain formation driven by cholesterol Biophys. J. 80 2001 2775 2788
20. K. Gousset, W.F. Wolkers, N.M. Tsvetkova, A.E. Oliver, C.L. Field, N.J. Walker, J.H. Crowe, and F. Tablin Evidence for a physiological role for membrane rafts in human platelets J. Cell. Physiol. 190 2002 117 128
21. J.M. Holopainen, M. Subramanian, and P.K.J. Kinnunen Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane Biochemistry 37 1998 17562 17570
22. H. Huang, E.M. Goldberg, and R. Zidovetzki Ceramides perturb the structure of phosphatidylcholine bilayers and modulate the activity of phospholipase A2 Eur. Biophys. J. 27 1998 361 366
23. H. Huang, E.M. Goldberg, and R. Zidovetzki Ceramide induces structural defects into phosphatidylcholine bilayers and activates phospholipase A2 Biochem. Biophys. Res. Commun. 220 1996 834 838
24. J.M. Holopainen, J.Y.A. Lehtonen, and P.K.J. Kinnunen Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes Chem. Phys. Lipids 88 1997 1 13
25. M.P. Veiga, J.L.R. Arrondo, F.M. Goñi, and A. Alonso Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases Biophys. J. 76 1999 342 350
26. J.M. Holopainen, J. Lemmich, F. Richter, O.G. Mouritsen, G. Rapp, and P.K.J. Kinnunen Dimyristoylphosphatidylcholine/C16:0-ceramide binary liposomes studied by differential scanning calorimetry and wide- and small-angle X-ray scattering Biophys. J. 78 2000 2459 2469
27. M.B. Ruiz-Argüello, G. Basáñez, F.M. Goñi, and A. Alonso Different effects of enzyme-generated ceramides and diacylglycerols in phospholipid membrane fusion and leakage J. Biol. Chem. 76 1996 342 350
28. G. Basáñez, M.B. Ruiz-Argüello, A. Alonso, F.M. Goñi, G. Karlsson, and K. Edwards Morphological changes induced by phospholipase C and by sphingomyelinase on large unilamellar vesicles: a cryo-transmission electron microscopy study of liposome fusion Biophys. J. 72 1997 2630 2637
29. T. Hevonoja, M.O. Pentikäinen, M.T. Hyvönen, P.T. Kovanen, and M. Ala-Korpela Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL Biochim. Biophys. Acta 1488 2000 189 210
30. R.N. Kolesnick, F.M. Goñi, and A. Alonso Compartmentalization of ceramide signaling: physical foundations and biological effects J. Cell. Physiol. 184 2000 285 300
31. J.C. Khoo, E. Miller, P. McLoughlin, and D. Steinberg Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I J. Lipid Res. 31 1990 645 652
32. H.S. Kruth Sequestration of aggregated low-density lipoproteins by macrophages Curr. Opin. Lipidol. 13 2002 483 488
33. W.L. Hendriks, F. Van der Sman-de Beer, B.J. Van Vlijmen, L.C. Van Vark, M.H. Hofker, and L.M. Havekes Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase Arterioscler. Thromb. Vasc. Biol. 17 1997 498 504
34. S.C. Whitman, S.L. Hazen, D.B. Miller, R.A. Hegele, J.W. Heinecke, and M.W. Huff Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages Arterioscler. Thromb. Vasc. Biol. 19 1999 1238 1249
35. I. Maor, T. Hayek, M. Hirsh, T.C. Iancu, and M. Aviram Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice Atherosclerosis 150 2000 91 101
36. S. Marathe, G. Kuriakose, K.J. Williams, and I. Tabas Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix Arterioscler. Thromb. Vasc. Biol. 19 1999 2648 2658
37. S. Bellosta, R.W. Mahley, D.A. Sanan, J. Murata, D.L. Newland, J.M. Taylor, and R.E. Pitas Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice J. Clin. Invest. 96 1995 2170 2179
38. A.H. Hasty, M.F. Linton, S.J. Brandt, V.R. Babaev, L.A. Gleaves, and S. Fazio Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation Circulation 99 1999 2571 2576